Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
Titel:
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
Auteur:
Castaneda, Carlos Meadows, Kellen L. Truax, Roxanne Morse, Michael A. Kaufmann, Scott H. Petros, William P. Zhu, Yali Statkevich, Paul Cutler, David L. Hurwitz, Herbert I.